Aion Therapeutic Inc. Reports Earnings Results for the Second Quarter and Six Months Ended October 31, 2022
For the six months, net income was CAD 0.682513 million compared to net loss of CAD 1.55 million a year ago. Basic earnings per share from continuing operations was CAD 0.005 compared to basic loss per share from continuing operations of CAD 0.01 a year ago. Diluted earnings per share from continuing operations was CAD 0.004 compared to diluted loss per share from continuing operations of CAD 0.01 a year ago.